Augmented antihypertensive effect of a fixed combination formula of candesartan and hydrochlorothiazide combined with furosemide in a patient on peritoneal dialysis

Clinical and Experimental Nephrology

Volumn 15, Issue 1, 2011, Pages 175-178

  Kuriyama, Satoru ^a   Otsuka, Yasushi ^a   Ueda, Hiroyuki ^a   Sugano, Naoki ^a   Yoshizawa, Takeo ^a   Yamada, Taku ^a   Hosoya, Tatsuo ^a  

^a JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Candesartan; Furosemide; Hydrochlorothiazide; Hypertension; Peritoneal dialysis

Indexed keywords

ALFACALCIDOL; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; BUNAZOSIN; CALCIUM CARBONATE; CANDESARTAN; CANDESARTAN PLUS HYDROCHLOROTHIAZIDE; ECARD; FUROSEMIDE; HYDROCHLOROTHIAZIDE; LONG ACTING INSULIN; UNCLASSIFIED DRUG;

ADULT; ANIHYPERTENSIVE ACTIVITY; ARTICLE; BODY WEIGHT; CASE REPORT; CHRONIC KIDNEY DISEASE; DIABETIC NEPHROPATHY; DIASTOLIC BLOOD PRESSURE; DRUG ACTIVITY; DRUG EFFICACY; DRUG RESPONSE; DRUG SUBSTITUTION; FEMALE; HUMAN; HYPERTENSION; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY FUNCTION; PATIENT COMPLIANCE; PERITONEAL DIALYSIS; SYSTOLIC BLOOD PRESSURE;

ADULT; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANTIHYPERTENSIVE AGENTS; BENZIMIDAZOLES; DIABETIC NEPHROPATHIES; DIURETICS; DRUG THERAPY, COMBINATION; FEMALE; FUROSEMIDE; HUMANS; HYDROCHLOROTHIAZIDE; HYPERTENSION; PERITONEAL DIALYSIS; TETRAZOLES;

EID: 79952185423     PISSN: 13421751     EISSN: 14377799     Source Type: Journal    
DOI: 10.1007/s10157-010-0355-3     Document Type: Article

References (10)

1. Guideline Committee of the Japanese Society of Hypertension. Guideline for the management of hypertension. Tokyo (in Japanese): Life Science Publishing Co.; 2009.
2. H Nakahama Y Orita M Yamazaki S Itoh T Okuda A Yamaji, et al. 1988 Pharmacokinetics and pharmacodynamic interactions between furosemide and hydrochlorothiazide in nephritic patients Nephron 49 223 227 1:STN:280:DyaL1c3ovVCqsw%3D%3D 10.1159/000185059 3398982
3. D Fliser M Schroter M Neubeck E Ritz 1994 Coadministration of thiazide increases the efficacy of loop diuretics even in patients with advanced renal failure Kidney Int 46 482 488 1:STN:280:DyaK2M%2Fls1ymug%3D%3D 10.1038/ki.1994.298 7967362 (Pubitemid 24253057)
4. Musini VM, Wright JM, Bassett K, Jauca CD. Blood pressure lowering efficacy of loop diuretics for primary hypertension. Cochran Database Syst Rev. 2009;(4):CD003825.
5. Chen JM, Heran BS, Wright JM. Blood pressure lowering efficacy of diuretics as second-line therapy for primary hypertension. Cochran Database Syst Rev. 2009;(4):CD007187.
6. Ronco C, Costanzo MR, Maisel AS, editors. Fluid overload: diagnosis and treatment. Contrib Nephrol, vol 164. Karger: Basel; 2010. p. 153-63.
7. H Knauf E Mutschler 1995 Diuretic effectiveness of hydrochlorothiazide and furosemide alone and in combination in chronic renal failure J Cardiovasc Pharmacol 26 394 400 1:CAS:528:DyaK2MXnvFeqsLc%3D 10.1097/00005344-199509000- 00008 8583780
8. T Saeki S Sakata H Asada K Wakami H Fukuda S Yamashita S Mukai K Kobayashi N Ohte G Kimuta 2008 The combined effect of thiazide diuretic and loop diuretic in cardio-renal patients Nippon Naika-Gakkai Zasshi 97 suppl 188 (Abstract in Japanese)
9. M Fukuda G Kimura 2006 Pathophysiology of antihypertensive therapy with diuretics Hypertens Res 29 9 645 653 1:CAS:528:DC%2BD28XhtlartrbE 10.1291/hypres.29.645 17249519 (Pubitemid 44605362)
10. Committee of CKD Initiative 2009 Clinical practice guidebook for diagnosis and treatment for chronic kidney disease; antihypertensive therapy Clin Exp Nephrol 13 3 231 233 10.1007/s10157-009-0147-9